<DOC>
	<DOC>NCT00479570</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of up to 200 mg of PF-00446687 on acute sexual arousal and sexual interest in post menopausal females, as well as examining the safety and toleration of the drug.</brief_summary>
	<brief_title>Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.</brief_title>
	<detailed_description />
	<criteria>Women who have evidence of Female Sexual Arousal Disorder. Women who experience personal distress due to Female Sexual Dysfunction. Post menopausal women aged between 45 and 65 years. Women whose sexual dysfunction is limited to certain types of stimulation, situation or specific partners. Women who experience pain with sexual intercourse or who have a sexual aversion disorder. Women suffering from female sexual dysfunction where the cause is treatable, for example inadequately controlled diabetes or thyroid dysfunction.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>